Salicylic Acid

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of common warts and plantar warts. Common warts are characterized by a rough, 'cauliflower-like' surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting with tenderness and an interruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and warts may be soaked in warm water for approximately 5 minutes to facilitate treatment. After soaking, the area must be dried completely.

Using the provided applicator, one drop of the medication should be carefully applied to each wart, ensuring that the entire wart is sufficiently covered. It is important to allow the application to dry completely before proceeding.

This procedure may be repeated once or twice daily as necessary, continuing until the wart is removed, for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

• In patients with diabetes or poor blood circulation, due to the increased risk of complications.

• On genital warts or warts located on the face or mucous membranes, as these areas may be sensitive and prone to adverse reactions.

• On moles, birthmarks, or warts with hair growing from them, to avoid potential irritation or complications.

• On irritated skin or any area that is infected or reddened, as this may exacerbate the condition and lead to further complications.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire or flame to prevent any risk of ignition.

The product should not be used in the following circumstances:

• In individuals with diabetes or those who exhibit poor blood circulation.

• On genital warts, warts located on the face, or any warts on mucous membranes.

• On moles, birthmarks, or warts that have hair growing from them.

• On skin that is irritated or on any area that appears infected or reddened.

When using this product, it is crucial to take the following precautions:

• In the event that the product comes into contact with the eyes, it is imperative to flush the eyes with water for at least 15 minutes.

• Users should avoid inhaling vapors to minimize respiratory irritation.

• The bottle should be capped tightly after use and stored at room temperature, away from heat sources.

If discomfort persists after application, users are advised to discontinue use and consult a healthcare professional for further evaluation.

This product must be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

Side Effects

Patients should be aware that this product is for external use only and is flammable; it should be kept away from fire or flame. The use of this product is contraindicated in individuals who are diabetic or have poor blood circulation. It should not be applied to genital warts, warts on the face or mucous membranes, moles, birthmarks, or warts with hair growing from them. Additionally, it should not be used on irritated skin or any area that is infected or reddened.

While using this product, if it comes into contact with the eyes, it is important to flush the eyes with water for 15 minutes. Patients should also avoid inhaling vapors and ensure that the bottle is capped tightly and stored at room temperature, away from heat.

Patients are advised to discontinue use and consult a doctor if discomfort persists. Furthermore, this product should be kept out of reach of children. In the event of accidental ingestion, medical help should be sought immediately, or contact a Poison Control Center.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (liquid wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is currently no information available regarding the use of Salicylic Acid Liquid Wart Remover during pregnancy. This includes a lack of data on safety concerns, dosage modifications, or any special precautions that should be taken when considering the use of this product in pregnant patients. Healthcare professionals should exercise caution and consider the absence of data when advising women of childbearing potential regarding the use of this product during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this product in lactating mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are advised to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that individuals with diabetes or poor blood circulation should refrain from using this product.

Patients should be cautioned against using the product on genital warts, warts located on the face, or any mucous membranes. Additionally, they should not apply it to moles, birthmarks, or warts that have hair growing from them. Providers should emphasize that the product should not be used on irritated skin or any area that appears infected or reddened.

Patients should be instructed to discontinue use and consult a healthcare professional if discomfort persists. In the event that the product comes into contact with the eyes, patients should be advised to flush the eyes with water for 15 minutes.

Healthcare providers should also remind patients to avoid inhaling vapors from the product. Finally, it is essential to instruct patients to cap the bottle tightly and store it at room temperature, away from heat sources.

Storage and Handling

The product is supplied in a container that must be stored at a temperature range of 20° to 25°C (68° to 77°F). It is essential to close the container tightly after each use to prevent solidification. The top of the bottle should be wiped clean following each application to maintain hygiene and product integrity.

Care should be taken to avoid contact with surrounding skin during application. Additionally, the product must not come into contact with fabrics, floors, countertops, or other surfaces, as it may cause staining. It is also crucial to keep the product away from fire or flame.

The product should be discarded when signs of the wart no longer appear.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)